Bullous pemphigoid during ustekinumab therapy
نویسندگان
چکیده
BP: Bullous pemphigoid TNF-a: tumor necrosis factor-alfa INTRODUCTION Ustekinumab, a monoclonal antibody that blocks interleukin-12 and interleukin-23, is a biological therapy used to treat moderate-to-severe psoriasis. Bullous pemphigoid (BP) induced by antietumor necrosis factor-alfa (TNF-a) agents has been described in the literature. No cases have been reported with ustekinumab. We report a case of BP occurring in a patient treated for 9 months with ustekinumab for severe psoriasis.
منابع مشابه
Serum protein carbonyl and total antioxidant capacity levels in pemphigus vulgaris and bullous pemphigoid
Background: Pemphigus diseases including pemphigus vulgaris (PV) and bullous pemphigoid (BP) are autoimmune diseases that cause severe blistering of the skin and mucous membranes. Among inflammatory mediators, reactive oxygen species (ROS) are involved in the pathogenesis of a wide variety of diseases through oxidative stress for which protein carbonyl (PC) and total antioxidant capacity (TAC) ...
متن کاملLocalized genital bullous pemphigoid; A case report
Bullous pemphigoid (BP) is an autoimmune bullous disorder with urticarial pruritic papules and plaques and tense bullae in flexural surfaces of body. The localized form of the disease is a rare variant which can be triggered by different stimuli. Hereunder, we report a patient with the local type involving genitalia without any triggering factors.
متن کاملBullous Pemphigoid: A descriptive study on patients admitted in Loghman Hakim Hospital in Tehran in 1992-97
Background: Most of patients with bullous pemphigoid are at old age and its differentiation from other bullous diseases is important. There is no report of it in Iran. Objective: This study was done in order to determine clinical and paraclinical features, natural course and response to treatment in patients with bullous pemphigoid admitted in Loghman Hakim Hospital in 1992-1997. Patients and M...
متن کاملDevelopment of bullous pemphigoid during nivolumab therapy
Bregs: B regulatory cells BP: bullous pemphigoid CTLA-4: cytotoxic T-lymphocyteeassociated protein 4 IRAE: immune-related adverse events PD-1: programmed cell death protein 1 PD-L1: programmed death ligand
متن کاملAssociation between HLA-DQB1*03:01 and Bullous Pemphigoid in Iranian Patients
Background: A common Human Leukocyte Antigen (HLA) class II allele, DQβ1*03:01, seems to be associated with Bullous pemphigoid (BP) in Caucasians whereas previous studies in other ethnic groups showed other HLA class II alleles as genetic predisposing factors for BP. Objective: To investigate the association of HLA class II alleles and haplotypes with BP in Iranian population. Methods: Fifty pa...
متن کامل